NPD SEC-arkiveringar - China Nepstar Chain Drugstore Ltd.- Årsredovisning, Fullmaktsutlåtande, prospekt

Grundläggande statistik

CIK

1414850

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to China Nepstar Chain Drugstore Ltd.

SEC Filings (Chronological Order)

Denna sida innehåller en komplett, kronologisk lista över SEC-arkiveringar, exklusive ägande-arkiveringar som vi tillhandahåller på andra ställen.

August 15, 2016	15-12B	China Nepstar Chain Drugstore 15-12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-33751 China Nepstar Chain Drugstore Ltd. (Exact name of registrant as spe
August 4, 2016	EX-99.25	EX-99.25 NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on August 15, 2016, pursuant to the provisions of Rule 12d2-2 (a).
August 4, 2016	SC 13D/A	NPD / China Nepstar Chain Drugstore Ltd. / Zhang Simin Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Name of Issuer) Ordinary shares, par value US$0.0001 per share (Title of Class of Securities) 16943C109(1) (CUSIP Number) Simin Zhang 28F, Neptunus Yinhe Keji Building No.1, Kejizhong 3rd Road Nanshan District, Shenzhe
August 3, 2016	S-8 POS	China Nepstar Chain Drugstore S-8 POS UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 China Nepstar Chain Drugstore Ltd. (Exact name of registrant as specified in its charter) Cayman Islands Not Applicable (state or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 25F, Nept
August 3, 2016	EX-99.1	1 Exhibit 99.1 China Nepstar Chain Drugstore Ltd. Announces Completion of Merger SHENZHEN, China, August 3, 2016 - China Nepstar Chain Drugstore Ltd. (NYSE: NPD) (?Nepstar? or the ?Company?), a leading retail drugstore chain in China based on the number of directly operated stores, announced today the completion of its merger (the ?merger?) with Neptunus Global Limited (?Merger Sub?), a wholly-owned
August 3, 2016	6-K	China Nepstar Chain Drugstore FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2016 Commission Filing Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant?s name into English) 25F, Neptunus Yinhe Keji Building No.1, Kejizhong 3rd Road, Nansh
August 3, 2016	SC 13E3/A	NPD / China Nepstar Chain Drugstore Ltd. / China Nepstar Chain Drugstore Ltd. - SC 13E3/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 6 TO SCHEDULE 13E-3 RULE 13e-3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 China Nepstar Chain Drugstore Ltd. (Name of the Issuer) China Nepstar Chain Drugstore Ltd. Mr. Simin Zhang China Neptunus Drugstore Holding Ltd. Neptunus Global Limited New Wave Developments Limited (Na
July 29, 2016	EX-99.1	China Nepstar Chain Drugstore Ltd. Announces Shareholders Vote to Approve Merger Exhibit 99.1 China Nepstar Chain Drugstore Ltd. Announces Shareholders Vote to Approve Merger SHENZHEN, China, July 29, 2016 - China Nepstar Chain Drugstore Ltd. (NYSE: NPD) (?Nepstar? or the ?Company?), a leading retail drugstore chain in China based on the number of directly operated stores, announced today that, at an extraordinary general meeting of the Company's shareholders held on July 29,
July 29, 2016	6-K	China Nepstar Chain Drugstore FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2016 Commission Filing Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant?s name into English) 25F, Neptunus Yinhe Keji Building No.1, Kejizhong 3rd Road, Nanshan
June 22, 2016	6-K	China Nepstar Chain Drugstore FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2016 Commission Filing Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant?s name into English) 25F, Neptunus Yinhe Keji Building No.1, Kejizhong 3rd Road, Nanshan
June 22, 2016	EX-99.1	China Nepstar Chain Drugstore Ltd. Announces Extraordinary General Meeting of Shareholders EX-99.1 2 v440468ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 China Nepstar Chain Drugstore Ltd. Announces Extraordinary General Meeting of Shareholders SHENZHEN, China, June 22, 2016 - China Nepstar Chain Drugstore Ltd. (NYSE: NPD) (“Nepstar” or the “Company”), a leading retail drugstore chain in China based on the number of directly operated stores, announced today that it has called an extraordinary ge
June 22, 2016	EX-99.A1	China Nepstar Chain Drugstore Ltd. Exhibit (a)-(1) China Nepstar Chain Drugstore Ltd. June 22, 2016 Shareholders of China Nepstar Chain Drugstore Ltd. Re: Notice of Extraordinary General Meeting of Shareholders You are cordially invited to attend an extraordinary general meeting of shareholders of China Nepstar Chain Drugstore Ltd. (the “Company”) to be held on July 29, 2016 at 10:00 a.m. (Beijing Time). The meeting will be held at
June 22, 2016	SC 13E3/A	NPD / China Nepstar Chain Drugstore Ltd. / China Nepstar Chain Drugstore Ltd. - SC 13E3/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 5 TO SCHEDULE 13E-3 RULE 13e-3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 China Nepstar Chain Drugstore Ltd. (Name of the Issuer) China Nepstar Chain Drugstore Ltd. Mr. Simin Zhang China Neptunus Drugstore Holding Ltd. Neptunus Global Limited New Wave Developments Limited (Na
May 31, 2016	6-K	China Nepstar Chain Drugstore FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2016 Commission Filing Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant?s name into English) 25F, Neptunus Yinhe Keji Building No.1, Kejizhong 3rd Road, Nanshan
May 31, 2016	EX-99.1	China Nepstar Chain Drugstore Ltd. Reports First Quarter 2016 Financial Results EX-99.1 2 v441307ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 China Nepstar Chain Drugstore Ltd. Reports First Quarter 2016 Financial Results SHENZHEN, China, May 31, 2016 — China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"), a leading retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the first quar
May 11, 2016	SC 13E3/A	NPD / China Nepstar Chain Drugstore Ltd. / China Nepstar Chain Drugstore Ltd. - SC 13E3/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 4 TO SCHEDULE 13E-3 RULE 13e-3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 China Nepstar Chain Drugstore Ltd. (Name of the Issuer) China Nepstar Chain Drugstore Ltd. Mr. Simin Zhang China Neptunus Drugstore Holding Ltd. Neptunus Global Limited New Wave Developments Limited (Na
May 11, 2016	CORRESP	China Nepstar Chain Drugstore ESP Solicitors and International Lawyers 12TH FLOOR GLOUCESTER TOWER \| THE LANDMARK \| 15 QUEEN?S ROAD CENTRAL \| HONG KONG WWW.
May 11, 2016	EX-99.A1	China Nepstar Chain Drugstore Ltd. Exhibit (a)-(1) China Nepstar Chain Drugstore Ltd. , 2016 Shareholders of China Nepstar Chain Drugstore Ltd. Re: Notice of Extraordinary General Meeting of Shareholders You are cordially invited to attend an extraordinary general meeting of shareholders of China Nepstar Chain Drugstore Ltd. (the “Company”) to be held on , 2016 at a.m. (Beijing Time). The meeting will be held at the Company’s offic
May 4, 2016	CORRESP	China Nepstar Chain Drugstore ESP Solicitors and International Lawyers 12TH FLOOR GLOUCESTER TOWER \| THE LANDMARK \| 15 QUEEN?S ROAD CENTRAL \| HONG KONG WWW.
May 4, 2016	EX-99.A1	China Nepstar Chain Drugstore Ltd. Exhibit (a)-(1) China Nepstar Chain Drugstore Ltd. , 2016 Shareholders of China Nepstar Chain Drugstore Ltd. Re: Notice of Extraordinary General Meeting of Shareholders You are cordially invited to attend an extraordinary general meeting of shareholders of China Nepstar Chain Drugstore Ltd. (the “Company”) to be held on , 2016 at a.m. (Beijing Time). The meeting will be held at the Company’s offic
May 4, 2016	SC 13E3/A	NPD / China Nepstar Chain Drugstore Ltd. / China Nepstar Chain Drugstore Ltd. - SC 13E3/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 3 TO SCHEDULE 13E-3 RULE 13e-3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 China Nepstar Chain Drugstore Ltd. (Name of the Issuer) China Nepstar Chain Drugstore Ltd. Mr. Simin Zhang China Neptunus Drugstore Holding Ltd. Neptunus Global Limited New Wave Developments Limited (Na
April 29, 2016	SC 13E3/A	NPD / China Nepstar Chain Drugstore Ltd. / China Nepstar Chain Drugstore Ltd. - SC 13E3/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO SCHEDULE 13E-3 RULE 13e-3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 China Nepstar Chain Drugstore Ltd. (Name of the Issuer) China Nepstar Chain Drugstore Ltd. Mr. Simin Zhang China Neptunus Drugstore Holding Ltd. Neptunus Global Limited New Wave Developments Limited (Na
April 29, 2016	CORRESP	China Nepstar Chain Drugstore ESP Solicitors and International Lawyers 12TH FLOOR GLOUCESTER TOWER \| THE LANDMARK \| 15 QUEEN?S ROAD CENTRAL \| HONG KONG WWW.
April 29, 2016	EX-99.A1	China Nepstar Chain Drugstore Ltd. EX-99.A1 2 v438211exa-1.htm EXHIBIT (A)-(1) Exhibit (a)-(1) China Nepstar Chain Drugstore Ltd. , 2016 Shareholders of China Nepstar Chain Drugstore Ltd. Re: Notice of Extraordinary General Meeting of Shareholders You are cordially invited to attend an extraordinary general meeting of shareholders of China Nepstar Chain Drugstore Ltd. (the “Company”) to be held on , 2016 at a.m. (Beijing Time). The
April 26, 2016	EX-4.5.7	ENTRUSTMENT LOAN AGREEMENT (this “Agreement”) (For Corporate Business) Serial No. : Xing Yin Shen Tian An Wei Jie Zi (2015) No. 0006 EX-4.5.7 2 v435322ex4-5x7.htm EXHIBIT 4.5.7 Exhibit 4.5.7 ENTRUSTMENT LOAN AGREEMENT (this “Agreement”) (For Corporate Business) Serial No. : Xing Yin Shen Tian An Wei Jie Zi (2015) No. 0006 Entrustor : Shenzhen Nepstar Pharmaceutical Co., Ltd. (affixed with the corporate seal) Domicile : Neptunus Yinhe Keji Building, Kejizhong 3rd Road, Shenzhen Legal Representative/Principal Officer : Zhang Ying
April 26, 2016	EX-4.5.8	ENTRUSTMENT LOAN AGREEMENT (this “Agreement”) (For Corporate Business) Serial No. : Xing Yin Shen Tian An Wei Jie Zi (2015) No. 0007 Exhibit 4.5.8 ENTRUSTMENT LOAN AGREEMENT (this “Agreement”) (For Corporate Business) Serial No. : Xing Yin Shen Tian An Wei Jie Zi (2015) No. 0007 Entrustor : Shenzhen Nepstar Pharmaceutical Co., Ltd. (affixed with the corporate seal) Domicile : Neptunus Yinhe Keji Building, Kejizhong 3rd Road, Shenzhen Legal Representative/Principal Officer : Zhang Yingnan Contact Person : Title : Mailing Address
April 26, 2016	EX-13.2	Certification by the Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Exhibit 13.2 Certification by the Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of China Nepstar Chain Drugstore Ltd. (the “Company”) on Form 20-F for the year ended December 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Zixin Shao, Chief Financial Officer of the Company,
April 26, 2016	EX-12.1	Certification by the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 Exhibit 12.1 Certification by the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Yingnan (Rebecca) Zhang, certify that: 1. I have reviewed this annual report on Form 20-F of China Nepstar Chain Drugstore Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the st
April 26, 2016	20-F	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ¨ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES E
April 26, 2016	EX-12.2	Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 Exhibit 12.2 Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Zixin Shao, certify that: 1. I have reviewed this annual report on Form 20-F of China Nepstar Chain Drugstore Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made
April 26, 2016	EX-13.1	Certification by the Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Exhibit 13.1 Certification by the Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of China Nepstar Chain Drugstore Ltd. (the “Company”) on Form 20-F for the year ended December 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Yingnan (Rebecca) Zhang, Chief Executive Officer of
April 21, 2016	CORRESP	China Nepstar Chain Drugstore ESP Solicitors and International Lawyers 12TH FLOOR GLOUCESTER TOWER \| THE LANDMARK \| 15 QUEEN?S ROAD CENTRAL \| HONG KONG WWW.
April 21, 2016	SC 13E3/A	NPD / China Nepstar Chain Drugstore Ltd. / China Nepstar Chain Drugstore Ltd. - FORM SC 13E3/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO SCHEDULE 13E-3 RULE 13e-3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 China Nepstar Chain Drugstore Ltd. (Name of the Issuer) China Nepstar Chain Drugstore Ltd. Mr. Simin Zhang China Neptunus Drugstore Holding Ltd. Neptunus Global Limited New Wave Developments Limited (Na
April 21, 2016	EX-99.(A)(1)	China Nepstar Chain Drugstore Ltd. Exhibit (a)-(1) China Nepstar Chain Drugstore Ltd. , 2016 Shareholders of China Nepstar Chain Drugstore Ltd. Re: Notice of Extraordinary General Meeting of Shareholders You are cordially invited to attend an extraordinary general meeting of shareholders of China Nepstar Chain Drugstore Ltd. (the “Company”) to be held on , 2016 at a.m. (Beijing Time). The meeting will be held at the Company’s offic
April 4, 2016	EX-99.C2	Draft – for discussion only CORPORATE FINANCE FINANCIAL ADVISORY SERVICES FINANCIAL RESTRUCTURING STRATEGIC CONSULTING HL.com Project Lily Preliminary Draft – Discussion Material September 7, 2015 华利安 Confidential Exhibit (C)-(2) Draft – for discussion only CORPORATE FINANCE FINANCIAL ADVISORY SERVICES FINANCIAL RESTRUCTURING STRATEGIC CONSULTING HL.
April 4, 2016	SC 13E3	NPD / China Nepstar Chain Drugstore Ltd. / China Nepstar Chain Drugstore Ltd. - SC 13E3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13E-3 RULE 13e-3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 China Nepstar Chain Drugstore Ltd. (Name of the Issuer) China Nepstar Chain Drugstore Ltd. Mr. Simin Zhang China Neptunus Drugstore Holding Ltd. Neptunus Global Limited New Wave Developments Limited (Names of Persons Fili
April 4, 2016	EX-99.A1	China Nepstar Chain Drugstore Ltd. Exhibit (a)-(1) China Nepstar Chain Drugstore Ltd. , 2016 Shareholders of China Nepstar Chain Drugstore Ltd. Re: Notice of Extraordinary General Meeting of Shareholders You are cordially invited to attend an extraordinary general meeting of shareholders of China Nepstar Chain Drugstore Ltd. (the “Company”) to be held on , 2016 at a.m. (Beijing Time). The meeting will be held at the Company’s offic
April 4, 2016	EX-99.B1	Commitment Letter Exhibit (b)-(1) Commitment Letter STRICTLY Private and confidential CHINA NEPTUNUS DRUGSTORE HOLDING LTD.
April 4, 2016	EX-99.C3	CORPORATE FINANCE FINANCIAL ADVISORY SERVICES FINANCIAL RESTRUCTURING STRATEGIC CONSULTING HL.com China Nepstar Chain Drugstore Ltd. Presentation to the Special Committee March 16, 2016 Confidential Exhibit (C)-(3) CORPORATE FINANCE FINANCIAL ADVISORY SERVICES FINANCIAL RESTRUCTURING STRATEGIC CONSULTING HL.
March 29, 2016	EX-99.1	China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2015 Financial Results Exhibit 99.1 China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2015 Financial Results SHENZHEN, China, March 29, 2015 - China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"), a leading retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the fourth quarter and fiscal year e
March 29, 2016	6-K	China Nepstar Chain Drugstore FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2016 Commission Filing Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant?s name into English) 25F, Neptunus Yinhe Keji Building No.1, Kejizhong 3rd Road, Nansha
March 17, 2016	EX-7.08	Commitment Letter Commitment Letter STRICTLY Private and confidential CHINA NEPTUNUS DRUGSTORE HOLDING LTD.
March 17, 2016	SC 13D	NPD / China Nepstar Chain Drugstore Ltd. / Zhang Simin Activist Investment SC 13D 1 zhang13d0317.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Name of Issuer) Ordinary shares, par value US$$0.0001 per share (Title of Class of Securities) 16943C109(1) (CUSIP Number) Simin Zhang 28F, Neptunus Yinhe Keji Building No.1, Kejizhong 3rd Roa
March 16, 2016	EX-99.1	China Nepstar Chain Drugstore Ltd. Enters into Definitive Merger Agreement for Going Private Transaction Exhibit 99.1 China Nepstar Chain Drugstore Ltd. Enters into Definitive Merger Agreement for Going Private Transaction SHENZHEN, China, March 16, 2016 - China Nepstar Chain Drugstore Ltd. (NYSE: NPD) (“Nepstar” or the “Company”), a leading retail drugstore chain in China based on the number of directly operated stores, announced today that it has entered into a definitive Agreement and Plan of Merg
March 16, 2016	6-K	China Nepstar Chain Drugstore FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2016 Commission Filing Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant?s name into English) 25F, Neptunus Yinhe Keji Building No.1, Kejizhong 3rd Road, Nansha
March 16, 2016	EX-99.2	AGREEMENT AND PLAN OF MERGER Dated as of March 16, 2016 among CHINA NEPTUNUS DRUGSTORE HOLDING LTD. NEPTUNUS GLOBAL LIMITED and CHINA NEPSTAR CHAIN DRUGSTORE LTD. Table of Contents Exhibit 99.2 AGREEMENT AND PLAN OF MERGER Dated as of March 16, 2016 among CHINA NEPTUNUS DRUGSTORE HOLDING LTD. NEPTUNUS GLOBAL LIMITED and CHINA NEPSTAR CHAIN DRUGSTORE LTD. Table of Contents Page ARTICLE I DEFINITIONS 1 SECTION 1.1 Certain Definitions 1 SECTION 1.2 Other Certain Definitions 8 ARTICLE II THE MERGER 10 SECTION 2.1 The Merger 10 SECTION 2.2 Closing of the Merger 10 SECTION 2.3 Eff
November 25, 2015	6-K	China Nepstar Chain Drugstore FORM 6-K (Current Report of Foreign Issuer) 6-K 1 v4256586k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2015 Commission Filing Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 25F, Neptunus Yinhe Keji Building
November 25, 2015	EX-99.1	China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2015 Financial Results Exhibit 99.1 China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2015 Financial Results SHENZHEN, China, Nov. 25, 2015 - China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"), a leading retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the third quarter ended September 30, 2015. Financial
September 2, 2015	6-K	China Nepstar Chain Drugstore FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2015 Commission Filing Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant?s name into English) 25F, Neptunus Yinhe Keji Building No.1, Kejizhong 3rd Road Nan
September 2, 2015	EX-99.1	China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2015 Financial Results EX-99.1 2 v419658ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2015 Financial Results SHENZHEN, China, September 2, 2015 - China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"), a leading retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the seco
August 6, 2015	EX-99.1	China Nepstar Chain Drugstore Ltd. Special Committee Retains Financial Advisor and Legal Counsel Exhibit 99.1 China Nepstar Chain Drugstore Ltd. Special Committee Retains Financial Advisor and Legal Counsel SHENZHEN, CHINA, August 6, 2015 - China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"), a leading retail drugstore chain in China based on the number of directly operated stores, today announced that the special committee (the "Special Committee") of the Company's bo
August 6, 2015	6-K	China Nepstar Chain Drugstore FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2015 Commission Filing Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant?s name into English) 25F, Neptunus Yinhe Keji Building No.1, Kejizhong 3rd Road Nansha
July 20, 2015	EX-99.1	China Nepstar Chain Drugstore Ltd. Announces Formation of Special Committee to Consider "Going Private" Proposal Exhibit 99.1 China Nepstar Chain Drugstore Ltd. Announces Formation of Special Committee to Consider "Going Private" Proposal SHENZHEN, July 17, 2015 - China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"), a leading retail drugstore chain in China based on the number of directly operated stores, today announced that its board of directors (the "Board") has formed a special c
July 20, 2015	6-K	China Nepstar Chain Drugstore FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2015 Commission Filing Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant?s name into English) 25F, Neptunus Yinhe Keji Building No.1, Kejizhong 3rd Road Nanshan
July 14, 2015	EX-7.01	Joint Filing Agreement Joint Filing Agreement In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13D referred to below) on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the ordinary shares of China Nepstar Chain Drugstore Ltd.
July 14, 2015	EX-7.04	English Translation English Translation Party A: Zhang Simin Party B: Huang Xiguang Reference is made to the Share Entrustment Agreement (Agreement No.
July 14, 2015	EX-7.03	Share Entrustment Agreement English Translation Share Entrustment Agreement Agreement No.: 20150501 Party A: Zhang Simin Party B: Huang Xiguang 　　 WHEREAS: 1. NEW WAVE DEVELOPMENTS LIMITED (the “Company”) is a limited liability company duly incorporated and existing in the British Virgin Island with its registered number of 1871697; 2. Party B is now holding 100% of the shares of the Company per Party A’s arrangement; 3. The
July 14, 2015	EX-7.05	NEW WAVE DEVELOPMENTS LIMITED (Incorporated in the British Virgin Islands with limited liability) INSTRUMENT OF TRANSFER NEW WAVE DEVELOPMENTS LIMITED (Incorporated in the British Virgin Islands with limited liability) INSTRUMENT OF TRANSFER I, HUANG Xiguang黄锡光 (“Transferor”) of Room 505, Building 1, No.
July 14, 2015	SC 13D	NPD / China Nepstar Chain Drugstore Ltd. / Zhang Simin Activist Investment SC 13D 1 zhang13d.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Name of Issuer) Ordinary shares, par value US$$0.0001 per share (Title of Class of Securities) 16943C109(1) (CUSIP Number) Simin Zhang 28F, Neptunus Yinhe Keji Building No.1, Kejizhong 3rd Road Nanshan District, She
July 10, 2015	SC 13D/A	NPD / China Nepstar Chain Drugstore Ltd. / Capital Eagle Global Ltd - SCHEDULE 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Amendment No. 1)* Under the Securities Exchange Act of 1934 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Name of Issuer) Ordinary shares, par value US$$0.0001 per share (Title of Class of Securities) 16943C109 (CUSIP Number) Henry Lu Capital Eagle Global Limited 59th Floor, Bank of China Tower 1 Garden Road Central, Hong
July 10, 2015	EX-99.3	SHARE PURCHASE AGREEMENT EX-99.3 2 v415256ex99-3.htm EXHIBIT 99.3 Exhibit 99.3 SHARE PURCHASE AGREEMENT This SHARE PURCHASE AGREEMENT (this “Agreement”) is entered into as of May 18, 2015, by and among Capital Eagle Global Limited, a British Virgin Islands corporation (the “Seller”) and New Wave Developments Limited, a British Virgin Islands corporation (the “Purchaser”). WHEREAS, the Purchaser agrees to purchase from the
July 6, 2015	6-K	China Nepstar Chain Drugstore 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2015 Commission Filing Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant?s name into English) 25F, Neptunus Yinhe Keji Building No.1, Kejizhong 3rd Road Nanshan
July 6, 2015	EX-99.1	China Nepstar Chain Drugstore Ltd. Announces Receipt of “Going Private” Proposal Exhibit 99.1 China Nepstar Chain Drugstore Ltd. Announces Receipt of “Going Private” Proposal SHENZHEN, China, July 6, 2015 - China Nepstar Chain Drugstore Ltd. (NYSE: NPD) (“Nepstar” or the “Company”), a leading retail drugstore chain in China based on the number of directly operated stores, today announced that its board of directors has received a preliminary non-binding proposal letter, dated
May 26, 2015	6-K	China Nepstar Chain Drugstore FORM 6-K (Current Report of Foreign Issuer) 6-K 1 v4115986k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2015 Commission Filing Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 25F, Neptunus Yinhe Keji Building No.1,
May 26, 2015	EX-99.1	China Nepstar Chain Drugstore Ltd. Reports First Quarter 2015 Financial Results Exhibit 99.1 China Nepstar Chain Drugstore Ltd. Reports First Quarter 2015 Financial Results SHENZHEN, China, May 26, 2015 — China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"), a leading retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the first quarter ended March 31, 2015. Financial Highl
May 22, 2015	6-K	China Nepstar Chain Drugstore FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2015 Commission Filing Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant?s name into English) 6th Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan Distric
May 22, 2015	EX-99.1	China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment Exhibit 99.1 China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment SHENZHEN, China, May 22, 2015 - China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"), a leading retail drugstore chain in China based on the number of directly operated stores, today announced the resignation of Mr. Fuxiang Zhang as the Company's Chief Executive Officer f
April 23, 2015	EX-12.1	Certification by the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 Exhibit 12.1 Certification by the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Fuxiang Zhang, certify that: 1. I have reviewed this annual report on Form 20-F of China Nepstar Chain Drugstore Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements m
April 23, 2015	EX-4.(5)(6)	ENTRUSTMENT LOAN AGREEMENT (For Corporate Business) Serial No.: Xing Yin Shen Tian An Wei Jie Zi (2014) No. 0019 Exhibit 4.5.6 English translation of Chinese original ENTRUSTMENT LOAN AGREEMENT (For Corporate Business) Serial No.: Xing Yin Shen Tian An Wei Jie Zi (2014) No. 0019 Entrustor: Shenzhen Nepstar Pharmaceutical Co., Ltd. (affixed with the corporate seal) Domicile: A-15B, Shenzhen Nanshan District Haiwang Building Legal Representative/Principal Officer: Zhang Simin Contact Person: Title: Mailing Add
April 23, 2015	EX-13.2	Certification by the Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Exhibit 13.2 Certification by the Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of China Nepstar Chain Drugstore Ltd. (the “Company”) on Form 20-F for the year ended December 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Zixin Shao, Chief Financial Officer of the Company,
April 23, 2015	EX-13.1	Certification by the Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Exhibit 13.1 Certification by the Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of China Nepstar Chain Drugstore Ltd. (the “Company”) on Form 20-F for the year ended December 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Fuxiang Zhang, Chief Executive Officer of the Compan
April 23, 2015	EX-12.2	Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 Exhibit 12.2 Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Zixin Shao, certify that: 1. I have reviewed this annual report on Form 20-F of China Nepstar Chain Drugstore Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made
April 23, 2015	EX-4.(5)(5)	ENTRUSTMENT LOAN AGREEMENT (For Corporate Business) Serial No.: Xing Yin Shen Tian An Wei Jie Zi (2014) No. 0020 Exhibit 4.5.5 English translation of Chinese original ENTRUSTMENT LOAN AGREEMENT (For Corporate Business) Serial No.: Xing Yin Shen Tian An Wei Jie Zi (2014) No. 0020 Entrustor: Shenzhen Nepstar Pharmaceutical Co., Ltd. (affixed with the corporate seal) Domicile: A-15B, Shenzhen Nanshan District Haiwang Building Legal Representative/Principal Officer: Zhang Simin Contact Person: Title: Mailing Add
April 23, 2015	20-F	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ¨ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES E
April 1, 2015	EX-99.1	China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results EXHIBIT 99.1 China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results SHENZHEN, China, March 30, 2015 - China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"), a leading retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the fourth quarter and fiscal year e
April 1, 2015	6-K	China Nepstar Chain Drugstore FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2015 Commission Filing Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant?s name into English) 25F, Neptunus Yinhe Keji Building No.1, Kejizhong 3rd Road, Nansha
December 31, 2014	6-K	NPD / China Nepstar Chain Drugstore Ltd. 6-K - Current Report of Foreign Issuer - FORM 6-K 6-K 1 v3978166k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2014 Commission Filing Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6th Floor, Tower B, Xinnengyuan Bu
December 31, 2014	EX-99.1	China Nepstar Chain Drugstore Announces $5 Million Share Repurchase Program EX-99.1 2 v397816ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 China Nepstar Chain Drugstore Announces $5 Million Share Repurchase Program SHENZHEN, China, December 30, 2014 - China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"), a leading retail drugstore chain in China based on the number of directly operated stores, today announced that the Company’s Board of Directors has authori
November 26, 2014	6-K	NPD / China Nepstar Chain Drugstore Ltd. 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2014 Commission Filing Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6th Floor, Tower B, Xinnengyuan Building Nanhai Road, Nanshan D
November 26, 2014	EX-99.2	China Nepstar Chain Drugstore Appoints Ms. Rebecca Yingnan Zhang as Chief Operating Officer Exhibit 99.2 China Nepstar Chain Drugstore Appoints Ms. Rebecca Yingnan Zhang as Chief Operating Officer SHENZHEN, China, November 26, 2014 — China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"), a leading retail drugstore chain in China based on the number of directly operated stores, today announced the appointment of Ms. Rebecca Yingnan Zhang as the Company's Chief Operat
November 26, 2014	EX-99.1	China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results Exhibit 99.1 China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results SHENZHEN, China, Nov 26, 2014 — China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"), a leading retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the third quarter ended September 30, 2014. Financial H
September 22, 2014	6-K	NPD / China Nepstar Chain Drugstore Ltd. 6-K - Current Report of Foreign Issuer - FORM 6-K Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2014 Commission Filing Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6th Floor, Tower B, Xinnengyuan Building Nanhai Road,
September 22, 2014	EX-99.1	China Nepstar Chain Drugstore Schedules Annual General Meeting of Shareholders for October 22, 2014 EX-99.1 Exhibit 99.1 China Nepstar Chain Drugstore Schedules Annual General Meeting of Shareholders for October 22, 2014 Shenzhen, China, September 22, 2014 – China Nepstar Chain Drugstore Ltd. (NYSE: NPD) (“Nepstar” or the “Company”), a leading retail drugstore chain in China based on the number of directly operated stores, today announced that it will hold its 2014 Annual General Meeting of Shar
August 28, 2014	EX-99.1	China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results EX-99.1 Exhibit 99.1 China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results SHENZHEN, China, August 28, 2014 /PRNewswire-FirstCall/ — China Nepstar Chain Drugstore Ltd. (NYSE: NPD) (“Nepstar” or the “Company”), a leading retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the second quarter e
August 28, 2014	6-K	NPD / China Nepstar Chain Drugstore Ltd. 6-K - Current Report of Foreign Issuer - FORM 6-K Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2014 Commission Filing Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6th Floor, Tower B, Xinnengyuan Building Nanhai Road, Na
June 18, 2014	EX-99.2	SHARE PURCHASE AGREEMENT EX-99.2 Exhibit 99.2 Execution Version SHARE PURCHASE AGREEMENT This SHARE PURCHASE AGREEMENT (this “Agreement”) is entered into as of May 12, 2014, by and among GS Capital Partners 2000, L.P., GS Capital Partners 2000 Employee Fund, L.P., Goldman Sachs Direct Investment Fund 2000, L.P., each a Delaware limited partnership, GS Capital Partners 2000 Offshore, L.P., a Cayman Islands exempted limited
June 18, 2014	EX-99.1	Joint Filing Agreement EX-99.1 Exhibit 99.1 Joint Filing Agreement In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13D referred to below) on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the or
June 18, 2014	SC 13D	NPD / China Nepstar Chain Drugstore Ltd. / Capital Eagle Global Ltd - SCHEDULE 13D Activist Investment SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Name of Issuer) Ordinary shares, par value US$0.0001 per share (Title of Class of Securities) 16943C109 (CUSIP Number) Henry Lu Capital Eagle Global Limited 59th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong Fa
June 13, 2014	EX-99.1	China Nepstar Chain Drugstore Announces Change of Director EX-99.1 Exhibit 99.1 China Nepstar Chain Drugstore Announces Change of Director SHENZHEN, China, June. 13, 2014 — China Nepstar Chain Drugstore Ltd. (NPD) (“Nepstar” or the “Company”), a leading retail drugstore chain in China based on the number of directly operated stores, today announced, on June 6, 2014, Ms. Stephanie Hui resigned from her position as a director of the Company, effective immed
June 13, 2014	6-K	Current Report of Foreign Issuer - FORM 6-K Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2014 Commission Filing Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6th Floor, Tower B, Xinnengyuan Building Nanhai Road, Nans
May 29, 2014	EX-99.1	China Nepstar Chain Drugstore Ltd. Reports First Quarter 2014 Financial Results EX-99.1 Exhibit 99.1 China Nepstar Chain Drugstore Ltd. Reports First Quarter 2014 Financial Results SHENZHEN, China, May 29, 2014 /PRNewswire-FirstCall/ — China Nepstar Chain Drugstore Ltd. (NYSE: NPD) (“Nepstar” or the “Company”), a leading retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the first quarter ended
May 29, 2014	6-K	Current Report of Foreign Issuer - FORM 6-K Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2014 Commission Filing Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6th Floor, Tower B, Xinnengyuan Building Nanhai Road, Nasha
April 22, 2014	EX-4.5.2	Exhibit 4.5.2 Exhibit 4.5.2 English translation of the Chinese original ENTRUSTMENT LOAN AGREEMENT (For Corporate Business) Serial No.: Xing Yin Shen Tian An Wei Jie Zi (2013) No. 0006 Entrustor: Shenzhen Nepstar Pharmaceutical Co., Ltd. (affixed with the corporate seal) Domicile: Legal Representative/Principal Officer: Contact Person: Title: Mailing Address: Postal Code: Telex: Telephone Number: Facsimile: Len
April 22, 2014	20-F	- FORM 20-F Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ¨ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) O
April 22, 2014	EX-13.1	Exhibit 13.1 EX-13.1 Exhibit 13.1 Certification by the Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of China Nepstar Chain Drugstore Ltd. (the “Company”) on Form 20-F for the year ended December 31, 2013 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Fuxiang Zhang, Chief Executive Officer of th
April 22, 2014	EX-4.5.1	Exhibit 4.5.1 EX-4.5.1 2 d617665dex451.htm EX-4.5.1 Exhibit 4.5.1 English translation of the Chinese original ENTRUSTMENT LOAN AGREEMENT (For Corporate Business) Serial No.: Xing Yin Shen Tian An Wei Jie Zi (2013) No. 0005 Entrustor: Shenzhen Nepstar Pharmaceutical Co., Ltd. (affixed with the corporate seal) Domicile: Legal Representative/Principal Officer: Contact Person: Title: Mailing Address: Postal Code: T
April 22, 2014	EX-12.1	Exhibit 12.1 EX-12.1 Exhibit 12.1 Certification by the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Fuxiang Zhang, certify that: 1. I have reviewed this annual report on Form 20-F of China Nepstar Chain Drugstore Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the stat
April 22, 2014	EX-12.2	Exhibit 12.2 EX-12.2 Exhibit 12.2 Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Zixin Shao, certify that: 1. I have reviewed this annual report on Form 20-F of China Nepstar Chain Drugstore Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the stateme
April 22, 2014	EX-13.2	Exhibit 13.2 EX-13.2 Exhibit 13.2 Certification by the Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of China Nepstar Chain Drugstore Ltd. (the “Company”) on Form 20-F for the year ended December 31, 2013 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Zixin Shao, Chief Financial Officer of the C
March 28, 2014	EX-99.1	China Nepstar Chain Drugstore Ltd. Unaudited Condensed Consolidated Statements of Income and Comprehensive Income (amounts in thousands – except per-share data) Three-month period ended Year ended December 31, December 31, 2012 2013 2013 2012 2013 20 EX-99.1 Exhibit 99.1 China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2013 Financial Results SHENZHEN, China, March 28, 2014 – China Nepstar Chain Drugstore Ltd. (NYSE: NPD) (“Nepstar” or the “Company”), the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the fourth quarter and fis
March 28, 2014	6-K	Current Report of Foreign Issuer - FORM 6-K Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2014 Commission Filing Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6th Floor, Tower B, Xinnengyuan Building Nanhai Road, Nas
January 15, 2014	CORRESP	- Correspondence VIA EDGAR CORRESP January 15, 2014 Jim B. Rosenberg, Senior Assistant Chief Accountant Dana Hartz, Staff Accountant Mary Mast, Senior Staff Accountant Division of Corporate Finance Securities and Exchange Commission 100 F Street, NE Washington, DC 20549-7010 Re: China Nepstar Chain Drugstore Ltd. Form 20-F for the Fiscal Year Ended December 31, 2012 Filed April 26, 2013 File No. 001
December 30, 2013	CORRESP	- Letter to the SEC Dated Dec 30, 2013 December 30, 2013 Jim B. Rosenberg, Senior Assistant Chief Accountant Dana Hartz, Staff Accountant Mary Mast, Senior Staff Accountant Division of Corporate Finance Securities and Exchange Commission 100 F Street, NE Washington, DC 20549-7010 Re: China Nepstar Chain Drugstore Ltd. Form 20-F for the Fiscal Year Ended December 31, 2012 Filed April 26, 2013 File No
November 26, 2013	EX-99.2	China Nepstar Chain Drugstore Announces Annual Dividend EX-99.2 Exhibit 99.2 China Nepstar Chain Drugstore Announces Annual Dividend SHENZHEN, China, November 26, 2013—China Nepstar Chain Drugstore Ltd. (NYSE: NPD) (“Nepstar” or the “Company”), the largest retail drugstore chain in China based on the number of directly operated stores, today announced that the Board of Directors has declared a annual cash dividend of US$0.32 per American Depositary Sha
November 26, 2013	EX-99.1	China Nepstar Chain Drugstore Reports Third Quarter 2013 Financial Results EX-99.1 Exhibit 99.1 China Nepstar Chain Drugstore Reports Third Quarter 2013 Financial Results SHENZHEN, China, November 26, 2013—China Nepstar Chain Drugstore Ltd. (NYSE: NPD) (“Nepstar” or the “Company”), the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the third quarter ended September 30, 2013. Fin
November 26, 2013	6-K	Current Report of Foreign Issuer - FORM 6-K Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2013 Commission Filing Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6th Floor, Tower B, Xinnengyuan Building Nanhai Road,
September 25, 2013	6-K	Current Report of Foreign Issuer - FORM 6-K Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2013 Commission Filing Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6th Floor, Tower B, Xinnengyuan Building Nanhai Road,
September 25, 2013	EX-99.1	China Nepstar Chain Drugstore Schedules Annual General Meeting of Shareholders for October 25, 2013 EX-99.1 Exhibit 99.1 China Nepstar Chain Drugstore Schedules Annual General Meeting of Shareholders for October 25, 2013 Shenzhen, China, September 25, 2013 – China Nepstar Chain Drugstore Ltd. (NYSE: NPD) (“Nepstar” or the “Company”), the largest drugstore chain in China based on the number of directly operated stores, today announced that it will hold its Annual General Meeting of Shareholders (
September 3, 2013	EX-99.1	China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2013 Financial Results EX-99.1 Exhibit 99.1 China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2013 Financial Results SHENZHEN, China, August 29, 2013 — China Nepstar Chain Drugstore Ltd. (NYSE: NPD) (“Nepstar” or the “Company”), the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the second quarter ended June 30, 2013. F
September 3, 2013	6-K	Current Report of Foreign Issuer - FORM 6-K Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2013 Commission Filing Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6th Floor, Tower B, Xinnengyuan Building Nanhai Road,
May 29, 2013	6-K	Current Report of Foreign Issuer - FORM 6-K Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of May, 2013 Commission File Number: 001- 33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD.
May 29, 2013	EX-99.2	China Nepstar Chain Drugstore Appoints New Director EX-99.2 Exhibit 99.2 China Nepstar Chain Drugstore Appoints New Director SHENZHEN, China, May 28, 2013 – China Nepstar Chain Drugstore Ltd. (NYSE: NPD) (“Nepstar” or the “Company”), the largest retail drugstore chain in China based on the number of directly operated stores, today announced the appointment of Mr. Alan Au as a director of the Company with effect from May 24th. Mr. Au currently serve
May 29, 2013	EX-99.1	China Nepstar Chain Drugstore Ltd. Reports First Quarter 2013 Financial Results Exhibit 99.1 China Nepstar Chain Drugstore Ltd. Reports First Quarter 2013 Financial Results SHENZHEN, China, May 28, 2013 – China Nepstar Chain Drugstore Ltd. (NYSE: NPD) (“Nepstar” or the “Company”), the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the first quarter ended March 31, 2013. Financial Hig
April 26, 2013	EX-4.5.10	Exhibit 4.5.10 Exhibit 4.5.10 English translation of the Chinese original ENTRUSTMENT LOAN AGREEMENT (For Corporate Business) Serial No.: Xing Yin Shen Tian An Wei Jie Zi (2012) No. 0005A Entrustor: Shenzhen Nepstar Pharmaceutical Co., Ltd. (affixed with the corporate seal) Domicile: Legal Representative/Principal Officer: Contact Person: Title: Mailing Address: Postal Code: Telex: Telephone Number: Facsimile: L
April 26, 2013	EX-13.1	Exhibit 13.1 EX-13.1 Exhibit 13.1 Certification by the Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of China Nepstar Chain Drugstore Ltd. (the “Company”) on Form 20-F for the year ended December 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Fuxiang Zhang, Chief Executive Officer of th
April 26, 2013	20-F	- FORM 20-F Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ¨ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) O
April 26, 2013	EX-12.2	Exhibit 12.2 EX-12.2 Exhibit 12.2 Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Zixin Shao, certify that: 1. I have reviewed this annual report on Form 20-F of China Nepstar Chain Drugstore Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the stateme
April 26, 2013	EX-12.1	Exhibit 12.1 EX-12.1 Exhibit 12.1 Certification by the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Fuxiang Zhang, certify that: 1. I have reviewed this annual report on Form 20-F of China Nepstar Chain Drugstore Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the stat
April 26, 2013	EX-4.5.9	Exhibit 4.5.9 EX-4.5.9 Exhibit 4.5.9 English translation of the Chinese original ENTRUSTMENT LOAN AGREEMENT (For Corporate Business) Serial No.: Xing Yin Shen Tian An Wei Jie Zi (2012) No. 0005 Entrustor: Shenzhen Nepstar Pharmaceutical Co., Ltd. (affixed with the corporate seal) Domicile: Legal Representative/Principal Officer: Contact Person: Title: Mailing Address: Postal Code: Telex: Telephone Number: Facsi
April 26, 2013	EX-13.2	Exhibit 13.2 EX-13.2 Exhibit 13.2 Certification by the Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of China Nepstar Chain Drugstore Ltd. (the “Company”) on Form 20-F for the year ended December 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Zixin Shao, Chief Financial Officer of the C
March 28, 2013	EX-99.1	China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2012 Financial Results - Same Store Sales Increased by 11.6% for the Fourth Quarter - EX-99.1 Exhibit 99.1 China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2012 Financial Results - Same Store Sales Increased by 11.6% for the Fourth Quarter - SHENZHEN, China, March 28, 2013 /PRNewswire-Asia-FirstCall/ — China Nepstar Chain Drugstore Ltd. (NYSE: NPD) (“Nepstar” or the “Company”), the largest retail drugstore chain in China based on the number of directly operated
March 28, 2013	6-K	Current Report of Foreign Issuer - FORM 6-K Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March, 2013 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6th Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan Dis
December 28, 2012	EX-99.1	China Nepstar Completes Disposition of 40% Equity Ownership in Yunnan Jianzhijia Chain Drugstore Press Release Exhibit 99.1 China Nepstar Completes Disposition of 40% Equity Ownership in Yunnan Jianzhijia Chain Drugstore SHENZHEN, China, December 28, 2012 China Nepstar Chain Drugstore Ltd. (NYSE: NPD) (“Nepstar” or the “Company”), the largest retail drugstore chain in China based on the number of directly operated stores, today announced that it has completed the sales of its 40% equity owner
December 28, 2012	6-K	Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December, 2012 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant?s name into English) 6th Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan District
November 28, 2012	EX-99.1	China Nepstar Chain Drugstore Reports Third Quarter 2012 Financial Results - Same Store Sales Increased by 12.8% - Press Release Exhibit 99.1 China Nepstar Chain Drugstore Reports Third Quarter 2012 Financial Results - Same Store Sales Increased by 12.8% - Shenzhen, China, November 28, 2012 – China Nepstar Chain Drugstore Ltd. (NYSE: NPD) (“Nepstar” or the “Company”), the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for
November 28, 2012	6-K	Current Report of Foreign Issuer - FORM 6-K Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November, 2012 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6th Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan
October 12, 2012	EX-99.1	China Nepstar Chain Drugstore Announces Resignation of Independent Director Press Release Exhibit 99.1 China Nepstar Chain Drugstore Announces Resignation of Independent Director SHENZHEN, China – October 11, 2012 – China Nepstar Chain Drugstore Ltd. (NYSE: NPD) (“China Nepstar” or the “Company”), the largest drugstore chain in China based on the number of directly operated stores, today announced that Mr. Gary Siu Kwan Sik has resigned as an independent director of the C
October 12, 2012	6-K	Current Report of Foreign Issuer - FORM 6-K Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October, 2012 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6th Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan D
September 26, 2012	6-K	Current Report of Foreign Issuer - FORM 6-K Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September, 2012 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6th Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan
September 26, 2012	EX-99.1	China Nepstar Chain Drugstore Schedules Annual General Meeting of Shareholders for October 26, 2012 PRESS RELEASE Exhibit 99.1 China Nepstar Chain Drugstore Schedules Annual General Meeting of Shareholders for October 26, 2012 Shenzhen, China, September 26, 2012 – China Nepstar Chain Drugstore Ltd. (NYSE: NPD) (“Nepstar” or the “Company”), the largest drugstore chain in China based on the number of directly operated stores, today announced that it will hold its Annual General Meeting of Sharehol
August 23, 2012	EX-99.1	China Nepstar Chain Drugstore Reports Second Quarter 2012 Financial Results - Same Store Sales Increased by 7.8% - EX-99.1 2 d401959dex991.htm PRESS RELEASE Exhibit 99.1 China Nepstar Chain Drugstore Reports Second Quarter 2012 Financial Results - Same Store Sales Increased by 7.8% - Shenzhen, China, August 23, 2012 – China Nepstar Chain Drugstore Ltd. (NYSE: NPD) (“Nepstar” or the “Company”), the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaud
August 23, 2012	6-K	Current Report of Foreign Issuer - FORM 6-K FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August, 2012 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6th Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan Di
May 31, 2012	EX-99.1	China Nepstar Chain Drugstore Reports First Quarter 2012 Financial Results - Same Store Sales Increased by 4.9% - PRESS RELEASE Exhibit 99.1 China Nepstar Chain Drugstore Reports First Quarter 2012 Financial Results - Same Store Sales Increased by 4.9% - Shenzhen, China, May 31, 2012 – China Nepstar Chain Drugstore Ltd. (NYSE: NPD) (“Nepstar” or the “Company”), the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the f
May 31, 2012	6-K	Current Report of Foreign Issuer - FORM 6-K Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May, 2012 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6th Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan Distr
April 27, 2012	EX-99.1	China Nepstar Chain Drugstore Announces Special Dividend Press Release Exhibit 99.1 China Nepstar Chain Drugstore Announces Special Dividend Shenzhen, China, April 27, 2012 – China Nepstar Chain Drugstore Ltd. (NYSE: NPD) (“Nepstar” or the “Company”), the largest retail drugstore chain in China based on the number of directly operated stores, today announced that the Board of Directors has declared a special cash dividend of US$0.60 per American Deposit
April 27, 2012	6-K	Current Report of Foreign Issuer - FORM 6-K Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April, 2012 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6th Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan Dis
April 24, 2012	20-F	- FORM 20-F 20-F 1 d238174d20f.htm FORM 20-F Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ¨ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2011 OR ¨ TRANSITION REPORT
April 24, 2012	EX-12.1	Exhibit 12.1 Certification by the Chief Executive Officer Pursuant to Section 302 Exhibit 12.1 Certification by the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Fuxiang Zhang, certify that: 1. I have reviewed this annual report on Form 20-F of China Nepstar Chain Drugstore Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fac
April 24, 2012	EX-12.2	Exhibit 12.2 Certification by the Chief Financial Officer Pursuant to Section 302 Exhibit 12.2 Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Zixin Shao, certify that: 1. I have reviewed this annual report on Form 20-F of China Nepstar Chain Drugstore Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact o
April 24, 2012	EX-13.2	Exhibit 13.2 Certification by the Chief Financial Officer Pursuant to Section 906 Exhibit 13.2 Certification by the Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of China Nepstar Chain Drugstore Ltd. (the “Company”) on Form 20-F for the year ended December 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (t
April 24, 2012	EX-4.5.7	Exhibit 4.5.7 Loan Agreement dated as of June 29, 2011 Exhibit 4.5.7 English translation of the Chinese original ENTRUSTMENT LOAN AGREEMENT (For Corporate Business) Serial No.: Xing Yin Shen Tian An Wei Jie Zi (2011) No. 0002 Entrustor: Shenzhen Nepstar Pharmaceutical Co., Ltd. (affixed with the corporate seal) Domicile: Legal Representative/Principal Officer: Contact Person: Title: Mailing Address: Postal Code
April 24, 2012	EX-4.5.8	Exhibit 4.5.8 Loan Agreement dated as of June 29, 2011 Exhibit 4.5.8 English translation of the Chinese original ENTRUSTMENT LOAN AGREEMENT (For Corporate Business) Serial No.: Xing Yin Shen Tian An Wei Jie Zi (2011) No. 0003 Entrustor: Shenzhen Nepstar Pharmaceutical Co., Ltd. (affixed with the corporate seal) Domicile: Legal Representative/Principal Officer: Contact Person: Title: Mailing Address: Postal Code
April 24, 2012	EX-13.1	Exhibit 13.1 Certification by the Chief Executive Officer Pursuant to Section 906 Exhibit 13.1 Certification by the Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of China Nepstar Chain Drugstore Ltd. (the “Company”) on Form 20-F for the year ended December 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (t
March 29, 2012	EX-99.1	China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2011 Financial Results - Same Store Sales Increase 9.7% for the Fourth Quarter - Exhibit 99.1 China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2011 Financial Results - Same Store Sales Increase 9.7% for the Fourth Quarter - Shenzhen, China, March 28, 2012 – China Nepstar Chain Drugstore Ltd. (NYSE: NPD) (“Nepstar” or the “Company”), the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited fin
March 29, 2012	6-K	Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March, 2012 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6th Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan District She
December 9, 2011	CORRESP	- Correspondence VIA EDGAR CORRESP December 9, 2011 Jim B. Rosenberg, Senior Assistant Chief Accountant Mary Mast, Senior Staff Accountant Tabatha Akins, Staff Accountant Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: China Nepstar Chain Drugstore Ltd. Form 20-F for the fiscal year ended December 31, 2010 Filed April 20, 2011 File No.
November 28, 2011	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November, 2011 Commission File Number: 001-33751 CHI UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November, 2011 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6th Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan District
November 28, 2011	EX-99.1	China Nepstar Chain Drugstore Reports Third Quarter 2011 Financial Results Exhibit 99.1 China Nepstar Chain Drugstore Reports Third Quarter 2011 Financial Results Shenzhen, China, November 28, 2011 – China Nepstar Chain Drugstore Ltd. (NYSE: NPD) (“Nepstar” or the “Company”), the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the third quarter ended September 30, 2011. Financial
November 16, 2011	CORRESP	- Correspondence VIA EDGAR November 16, 2011 Jim B. Rosenberg, Senior Assistant Chief Accountant Mary Mast, Senior Staff Accountant Tabatha Akins, Staff Accountant Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: China Nepstar Chain Drugstore Ltd. Form 20-F for the fiscal year ended December 31, 2010 Filed April 20, 2011 File No. 001-33
October 24, 2011	CORRESP	- Letter to SEC Dated 21 Oct 2011 VIA EDGAR CORRESP October 24, 2011 Jim B. Rosenberg, Senior Assistant Chief Accountant Mary Mast, Senior Staff Accountant Tabatha Akins, Staff Accountant Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: China Nepstar Chain Drugstore Ltd. Form 20-F for the fiscal year ended December 31, 2010 Filed April
October 11, 2011	EX-99.1	China Nepstar Chain Drugstore Schedules Annual General Meeting of Shareholders for October 25, 2011 Press Release Exhibit 99.1 China Nepstar Chain Drugstore Schedules Annual General Meeting of Shareholders for October 25, 2011 Shenzhen, China, September 22, 2011 – China Nepstar Chain Drugstore Ltd. (NYSE: NPD) (“Nepstar” or the “Company”), the largest drugstore chain in China based on the number of directly operated stores, today announced that it will hold its Annual General Meeting of Sharehol
October 11, 2011	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October, 2011 Commission File Number: 001-33751 CHIN 6-K 1 d241650d6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October, 2011 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6th Floor, Tower B, Xinnengyuan Building
September 28, 2011	CORRESP	- VIA EDGAR September 28, 2011 Jim B. Rosenberg, Senior Assistant Chief Accountant Mary Mast, Senior Staff Accountant Tabatha Akins, Staff Accountant Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: China Nepstar Chain Drugstore Ltd. Form 20-F for the fiscal year ended December 31, 2010 Filed April 20, 2011 File No. 001-33751 Dear Mr. R
September 6, 2011	CORRESP	- Correspondence VIA EDGAR September 6, 2011 Jim B. Rosenberg, Senior Assistant Chief Accountant Mary Mast, Senior Staff Accountant Tabatha Akins, Staff Accountant Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: China Nepstar Chain Drugstore Ltd. Form 20-F for the fiscal year ended December 31, 2010 Filed April 20, 2011 File No. 001-33
August 23, 2011	EX-99.1	China Nepstar Chain Drugstore Announces Share Repurchase Program EX-99.1 Exhibit 99.1 China Nepstar Chain Drugstore Announces Share Repurchase Program SHENZHEN, China, Aug. 23, 2011 /PRNewswire-Asia-FirstCall/ — China Nepstar Chain Drugstore Ltd. (NYSE: NPD) (“Nepstar” or the “Company”), the largest drugstore chain in China based on the number of directly operated stores, today announced that its board of directors has authorized a share repurchase program. Und
August 23, 2011	EX-99.3	China Nepstar Chain Drugstore Announces Management Change EX-99.3 Exhibit 99.3 China Nepstar Chain Drugstore Announces Management Change SHENZHEN, China, Aug. 23, 2011 /PRNewswire-Asia-FirstCall/ — China Nepstar Chain Drugstore Ltd. (NYSE: NPD) (“Nepstar” or the “Company”), the largest drugstore chain in China based on the number of directly operated stores, today announced the resignation of Mr. Jason Xinghua Wu as the Company’s Chief Executive Officer,
August 23, 2011	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August, 2011 Commission File Number: 001-33751 CHINA UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August, 2011 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6th Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan District Sh
August 23, 2011	EX-99.2	China Nepstar Chain Drugstore Reports Second Quarter 2011 Financial Results - Same Store Sales Increase 9.8% - Exhibit 99.2 China Nepstar Chain Drugstore Reports Second Quarter 2011 Financial Results - Same Store Sales Increase 9.8% - Shenzhen, China, August 23, 2011 – China Nepstar Chain Drugstore Ltd. (NYSE: NPD) (“Nepstar” or the “Company”), the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the second quarter
August 15, 2011	CORRESP	- Correspondence Letter dated August 15, 2011 VIA EDGAR August 15, 2011 Jim B. Rosenberg, Senior Assistant Chief Accountant Mary Mast, Senior Staff Accountant Tabatha Akins, Staff Accountant Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: China Nepstar Chain Drugstore Ltd. Form 20-F for the fiscal year ended December 31, 2010 Filed Apr
August 2, 2011	CORRESP	- Correspondence VIA EDGAR August 2, 2011 Jim B. Rosenberg, Senior Assistant Chief Accountant Mary Mast, Senior Staff Accountant Tabatha Akins, Staff Accountant Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: China Nepstar Chain Drugstore Ltd. Form 20-F for the fiscal year ended December 31, 2010 Filed April 20, 2011 File No. 001-33751
May 25, 2011	EX-99.1	China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results - Same Store Sales Increase 8.9% - Exhibit 99.1 China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results - Same Store Sales Increase 8.9% - Shenzhen, China, May 25, 2011 — China Nepstar Chain Drugstore Ltd. (NYSE: NPD) (“Nepstar” or “the Company”), the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the first quarter ended
May 25, 2011	6-K	FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2011 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGST Table of Contents FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2011 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6TH Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan District Shenz
April 20, 2011	EX-4.2.2	Exhibit 4.2.2 Exhibit 4.2.2 English Translation of Chinese Original Logistics Service and Information Technology Support Agreement This Logistics Service and Information Technology Support Agreement (hereinafter referred to as this “Agreement”) is entered into by and between the following parties on August 18, 2009 in Shenzhen: Party A: Shenzhen Nepstar Pharmaceutical Co., Ltd. Registered address: Neptunus Buil
April 20, 2011	EX-4.5.4	Exhibit 4.5.4 Exhibit 4.5.4 English Translation of Chinese Original ENTRUSTMENT LOAN AGREEMENT Serial No. Xing Yin Shen Tian An Wei Jie Zi (2010) No. 0005 Entrusting Party: Shenzhen Nepstar Pharmaceutical Co., Ltd. Mail Address: Neptunus Building A-15B, Nanshan District, Shenzhen Mail Code: Contact Tel.: Lender: Shenzhen Tian’an Branch of Industrial Bank Co., Ltd. Mail Address: Building A, Tian’an Innovation Te
April 20, 2011	EX-4.3.3	Exhibit 4.3.3 Exhibit 4.3.3 English Translation of Chinese Original TRADE NAME LICENSE AGREEMENT This Trade Name License Agreement (hereinafter referred to as this “Agreement”) is entered into by and between the following parties on May 28, 2010 in Shenzhen: Party A: Shenzhen Nepstar Pharmaceutical Co., Ltd. Registered address: Neptunus Building A-15B, Nanshan District, Shenzhen Party B: Shenzhen Nepstar E-Comm
April 20, 2011	EX-4.2.3	Exhibit 4.2.3 Exhibit 4.2.3 English Translation of Chinese Original Logistics Service and Information Technology Support Agreement This Logistics Service and Information Technology Support Agreement (hereinafter referred to as this “Agreement”) is entered into by and between the following parties on May 28, 2010 in Shenzhen: Party A: Shenzhen Nepstar Pharmaceutical Co., Ltd. Registered address: Neptunus Buildin
April 20, 2011	EX-13.1	Exhibit 13.1 Exhibit 13.1 EXHIBIT 13.1 Certification by the Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of China Nepstar Chain Drugstore Ltd. (the “Company”) on Form 20-F for the year ended December 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jason Xinghua Wu, Chief Executive Offic
April 20, 2011	20-F	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) o Registration statement pursuant to Section 12(b) or 12(g) of the Securities Exchange Act of 1934 or þ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2010 or o Transition report pursuant to Section 13 or 15(d) o
April 20, 2011	EX-12.2	Exhibit 12.2 Exhibit 12.2 EXHIBIT 12.2 Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Zixin Shao, certify that: 1. I have reviewed this annual report on Form 20-F of China Nepstar Chain Drugstore Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the st
April 20, 2011	EX-4.4.3	Exhibit 4.4.3 Exhibit 4.4.3 English Translation of Chinese Original PRODUCT SUPPLY AGREEMENT This Product Supply Agreement (hereinafter referred to as this “Agreement”) is entered into by and between the following parties on May 28, 2010 in Shenzhen: Party A: Shenzhen Nepstar Pharmaceutical Co., Ltd. Registered address: Neptunus Building A-15B, Nanshan District, Shenzhen Party B: Shenzhen Nepstar E-Commerce Co.
April 20, 2011	EX-4.4.2	Exhibit 4.4.2 Exhibit 4.4.2 English Translation of Chinese Original PRODUCT SUPPLY AGREEMENT This Product Supply Agreement (hereinafter referred to as this “Agreement”) is entered into by and between the following parties on August 18, 2009 in Shenzhen: Party A: Shenzhen Nepstar Pharmaceutical Co., Ltd. Registered address: Neptunus Building A-15B, Nanshan District, Shenzhen Party B: Fuzhou Nepstar Chain Co., Lt
April 20, 2011	EX-13.2	Exhibit 13.2 Exhibit 13.2 EXHIBIT 13.2 Certification by the Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of China Nepstar Chain Drugstore Ltd. (the “Company”) on Form 20-F for the year ended December 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Zixin Shao, Chief Financial Officer of
April 20, 2011	EX-12.1	Exhibit 12.1 Exhibit 12.1 EXHIBIT 12.1 Certification by the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Jason Xinghua Wu, certify that: 1. I have reviewed this annual report on Form 20-F of China Nepstar Chain Drugstore Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make
April 20, 2011	EX-4.18	Exhibit 4.18 Exhibit 4.18 Exhibit 4.18 English Translation of Chinese Original Supplement to Equity Pledge Agreement This Supplement to Equity Pledge Agreement (this “Supplemental Agreement”) is entered into by and between the following parties on May 28, 2010 in Shenzhen: PLEDGEE: Party A: Shenzhen Nepstar Pharmaceutical Co., Ltd. Registered address: Neptunus Building A-15B, Nanshan District, Shenzhen PLEDGOR
April 20, 2011	EX-4.3.2	Exhibit 4.3.2 Exhibit 4.3.2 Exhibit 4.3.2 English Translation of Chinese Original TRADE NAME LICENSE AGREEMENT This Trade Name License Agreement (hereinafter referred to as this “Agreement”) is entered into by and between the following parties on August 18, 2009 in Shenzhen: Party A: Shenzhen Nepstar Pharmaceutical Co., Ltd. Registered address: Neptunus Building A-15B, Nanshan District, Shenzhen Party B: Fuzhou
April 20, 2011	EX-4.5.6	Exhibit 4.5.6 Exhibit 4.5.6 Exhibit 4.5.6 English Translation of Chinese Original ENTRUSTMENT LOAN AGREEMENT Serial No. Xing Yin Shen Tian An Wei Jie Zi (2010) No. 0001-A Entrusting Party: Shenzhen Nepstar Pharmaceutical Co., Ltd. Mail Address: Neptunus Building A-15B, Nanshan District, Shenzhen Mail Code: Contact Tel.: Lender: Shenzhen Tian’an Branch of Industrial Bank Co., Ltd. Mail Address: Building A, Tian’
April 20, 2011	EX-4.5.5	Exhibit 4.5.5 Exhibit 4.5.5 Exhibit 4.5.5 English Translation of Chinese Original ENTRUSTMENT LOAN AGREEMENT Serial No. Xing Yin Shen Tian An Wei Jie Zi (2010) No. 0002-A Entrusting Party: Shenzhen Nepstar Pharmaceutical Co., Ltd. Mail Address: Neptunus Building A-15B, Nanshan District, Shenzhen Mail Code: Contact Tel.: Lender: Shenzhen Tian’an Branch of Industrial Bank Co., Ltd. Mail Address: Building A, Tian’
April 20, 2011	EX-4.5.3	Exhibit 4.5.3 exv4w5w3 Exhibit 4.5.3 English Translation of Chinese Original ENTRUSTMENT LOAN AGREEMENT Serial No. Xing Yin Shen Tian An Wei Jie Zi (2010) No. 0006 Entrusting Party: Shenzhen Nepstar Pharmaceutical Co., Ltd. Mail Address: Neptunus Building A-15B, Nanshan District, Shenzhen Mail Code: Contact Tel.: Lender: Shenzhen Tian’an Branch of Industrial Bank Co., Ltd. Mail Address: Building A, Tian’an Inno
March 16, 2011	6-K	FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2011 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUG Table of Contents FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2011 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6TH Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan District She
January 19, 2011	6-K	FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2011 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DR Table of Contents FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2011 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6TH Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan District S
November 17, 2010	6-K	FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2010 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN D Table of Contents FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2010 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6TH Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan District
August 16, 2010	6-K	FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2010 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRU Table of Contents FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2010 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6TH Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan District Sh
May 19, 2010	EX-99.1	China Nepstar Chain Drugstore Reports First Quarter 2010 Financial Results — Same Store Sales Growth 6.9% — Exhibit 99.1 China Nepstar Chain Drugstore Reports First Quarter 2010 Financial Results — Same Store Sales Growth 6.9% — Shenzhen, China, May 18, 2010 – China Nepstar Chain Drugstore Ltd. (NYSE: NPD) (“Nepstar” or “the Company”), the largest drugstore chain in China in terms of the number of directly operated stores, with 2,559 directly operated stores in operation as of March 31, 2010, today anno
May 19, 2010	6-K	FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2010 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGST Table of Contents FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2010 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6TH Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan District Shenz
April 30, 2010	20-F	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) o Registration statement pursuant to Section 12(b) or 12(g) of the Securities Exchange Act of 1934 or þ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2009 or o Transition report pursuant to Section 13 or 15(d) o
April 30, 2010	EX-12.1	Certification by the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 EXHIBIT 12.1 EXHIBIT 12.1 Certification by the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Ian F. Wade, certify that: 1. I have reviewed this annual report on Form 20-F of China Nepstar Chain Drugstore Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the s
April 30, 2010	EX-4.17	SUPPLEMENTAL AGREEMENT TO THE EQUITY PLEDGE AGREEMENT Exhibit 4.17 SUPPLEMENTAL AGREEMENT TO THE EQUITY PLEDGE AGREEMENT This Supplemental Agreement to the Equity Pledge Agreement (this “Supplemental Agreement”) is entered into by and between the following parties on [August 18], 2009 in [Shenzhen]: PLEDGEE: Party A: Shenzhen Nepstar Pharmaceutical Coompany Ltd. Registered address: Neptunus Building A-15B, Nanshan District, Shenzhen PLEDGORS: Party B
April 30, 2010	EX-12.2	Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 EXHIBIT 12.2 EXHIBIT 12.2 Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, William Weili Dai, certify that: 1. I have reviewed this annual report on Form 20-F of China Nepstar Chain Drugstore Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make
April 30, 2010	EX-13.2	Certification by the Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 EXHIBIT 13.2 EXHIBIT 13.2 Certification by the Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of China Nepstar Chain Drugstore Ltd. (the “Company”) on Form 20-F for the year ended December 31, 2009 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, William Weili Dai, Chief Financial Offi
April 30, 2010	EX-13.1	Certification by the Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 EXHIBIT 13.1 EXHIBIT 13.1 Certification by the Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of China Nepstar Chain Drugstore Ltd. (the “Company”) on Form 20-F for the year ended December 31, 2009 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Ian F. Wade, Chief Executive Officer of
March 5, 2010	6-K	FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2010 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUG Table of Contents FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2010 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6TH Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan District She
March 5, 2010	6-K	FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2010 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUG Table of Contents FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2010 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6TH Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan District She
January 4, 2010	6-K	FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2010 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DR Table of Contents FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2010 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6TH Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan District S
December 1, 2009	6-K	FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2009 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN D Table of Contents FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2009 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6TH Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan District
November 20, 2009	6-K	FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2009 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRU Table of Contents FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2009 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6TH Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan District Sh
May 27, 2009	6-K	FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2009 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGST Table of Contents FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2009 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6TH Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan District Shenz
May 26, 2009	EX-13.1	Certification by the Co-Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Exhibit 13.1 EXHIBIT 13.1 Certification by the Co-Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of China Nepstar Chain Drugstore Ltd. (the “Company”) on Form 20-F for the year ended December 31, 2008 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jiannong Qian, Co-Chief Executive Of
May 26, 2009	EX-13.2	Certification by the Co-Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Exhibit 13.2 EXHIBIT 13.2 Certification by the Co-Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of China Nepstar Chain Drugstore Ltd. (the “Company”) on Form 20-F for the year ended December 31, 2008 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Ian F. Wade, Co-Chief Executive Offi
May 26, 2009	20-F	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F 20-F 1 c86040e20vf.htm FORM 20-F Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) o Registration statement pursuant to Section 12(b) or 12(g) of the Securities Exchange Act of 1934 or þ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2008 or o Transition report
May 26, 2009	EX-12.3	Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 Exhibit 12.3 EXHIBIT 12.3 Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, William Weili Dai, certify that: 1. I have reviewed this annual report on Form 20-F of China Nepstar Chain Drugstore Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make
May 26, 2009	EX-12.1	Certification by the Co-Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 Exhibit 12.1 EXHIBIT 12.1 Certification by the Co-Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Jiannong Qian, certify that: 1. I have reviewed this annual report on Form 20-F of China Nepstar Chain Drugstore Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make
May 26, 2009	EX-12.2	Certification by the Co-Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 Exhibit 12.2 EXHIBIT 12.2 Certification by the Co-Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Ian F. Wade, certify that: 1. I have reviewed this annual report on Form 20-F of China Nepstar Chain Drugstore Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make th
May 26, 2009	EX-13.3	Certification by the Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Exhibit 13.3 EXHIBIT 13.3 Certification by the Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of China Nepstar Chain Drugstore Ltd. (the “Company”) on Form 20-F for the year ended December 31, 2008 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, William Weili Dai, Chief Financial Offi
March 16, 2009	6-K	FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2009 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUG Table of Contents FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2009 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6TH Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan District She
March 16, 2009	6-K	FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2009 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUG Table of Contents FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2009 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6TH Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan District She
January 5, 2009	6-K	FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2009 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DR Table of Contents FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2009 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6TH Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan District S
January 5, 2009	6-K	FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2009 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DR Table of Contents FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2009 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6TH Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan District S
November 26, 2008	6-K	FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2008 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN D Table of Contents FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2008 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6TH Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan District
August 27, 2008	6-K	FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 August 2008 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Tran Table of Contents FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 August 2008 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6TH Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan District Shenzhen, Guangdong
August 27, 2008	6-K	FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 August 2008 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Tran Table of Contents FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 August 2008 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6TH Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan District Shenzhen, Guangdong
August 27, 2008	6-K	FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 August 2008 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Tran Table of Contents FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 August 2008 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6TH Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan District Shenzhen, Guangdong
May 30, 2008	6-K	FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 May 30, 2008 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Tra FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 May 30, 2008 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6TH Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan District Shenzhen, Guangdong Province 518054
May 29, 2008	EX-15.1	Consent of Independent Registered Public Accounting Firm CONSENT OF INDEPENDENT REGISTERED PUBLIC A/C FIRM EXHIBIT 15.1 Consent of Independent Registered Public Accounting Firm The Board of Directors China Nepstar Chain Drugstore Ltd. We consent to the incorporation by reference in the Registration Statement (No.333-147702) on Form S-8 of China Nepstar Chain Drugstore Ltd. of our report dated April 25, 2008, with respect to the consolidated balance shee
May 29, 2008	EX-13.1	Certification by the Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 CERTIFICATION BY THE CEO PURSUANT TO SECTION 906 EXHIBIT 13.1 Certification by the Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of China Nepstar Chain Drugstore Ltd. (the “Company”) on Form 20-F for the year ended December 31, 2007 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jia
May 29, 2008	EX-12.2	Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 CERTIFICATION BY THE CFO PURSUANT TO SECTION 302 EXHIBIT 12.2 Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Andrew Weiwen Chen, certify that: 1. I have reviewed this annual report on Form 20-F of China Nepstar Chain Drugstore Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to st
May 29, 2008	EX-13.2	Certification by the Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 CERTIFICATION BY THE CFO PURSUANT TO SECTION 906 EXHIBIT 13.2 Certification by the Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of China Nepstar Chain Drugstore Ltd. (the “Company”) on Form 20-F for the year ended December 31, 2007 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, And
May 29, 2008	EX-12.1	Certification by the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 CERTIFICATION BY THE CEO PURSUANT TO SECTION 302 EXHIBIT 12.1 Certification by the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Jiannong Qian, certify that: 1. I have reviewed this annual report on Form 20-F of China Nepstar Chain Drugstore Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a
May 29, 2008	20-F	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) o Registration statement pursuant to Section 12(b) or 12(g) of the Securities Exchange Act of 1934 or þ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2007 or o Transition report pursuant to Section 13 or 15(d) o
May 29, 2008	6-K	FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 May 29, 2008 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Tra Table of Contents FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 May 29, 2008 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6TH Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan District Shenzhen, Guangdon
March 26, 2008	6-K	FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2008 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUG Table of Contents FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2008 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6TH Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan District She
March 19, 2008	6-K	FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2008 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUG Table of Contents FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2008 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6TH Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan District She
February 26, 2008	6-K	FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 February 26, 2008 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 February 26, 2008 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6TH Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan District Shenzhen, Guangdong Province 51
February 11, 2008	SC 13G	SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 China Nepstar Chain Drugstore Table of Contents SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 China Nepstar Chain Drugstore Ltd. (Name of Issuer) Ordinary Shares, par value US$0.0001 per share (Title of Class of Securities) 16943C 10 91 (CUSIP Number) Dec
February 11, 2008	EX-99.1	Joint Filing Agreement EX-99.1 JOINT FILING AGREEMENT EXHIBIT 99.1 Joint Filing Agreement In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments thereto)
December 12, 2007	6-K	FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2007 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN D FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2007 Commission File Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Translation of registrant’s name into English) 6TH Floor, Tower B, Xinnengyuan Building Nanhai Road, Nashan District Shenzhen, Guangdon
November 29, 2007	S-8	As Filed with the Securities and Exchange Commission on November 29, 2007 Table of Contents As Filed with the Securities and Exchange Commission on November 29, 2007 Registration No.
November 14, 2007	F-6 POS	As filed with the U.S. Securities and Exchange Commission on November 14, 2007 Table of Contents As filed with the U.S. Securities and Exchange Commission on November 14, 2007 Registration No. 333-146876 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 2 TO FORM F-6 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 For the American Depositary Shares Evidenced by American Depositary Receipts CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Exact
November 14, 2007	EX-1.A	DATED AS OF NOVEMBER 15, 2007 CHINA NEPSTAR CHAIN DRUGSTORE LTD. JPMORGAN CHASE BANK, N.A., As Depositary AND HOLDERS OF AMERICAN DEPOSITARY RECEIPTS DEPOSIT AGREEMENT EXHIBIT a DATED AS OF NOVEMBER 15, 2007 CHINA NEPSTAR CHAIN DRUGSTORE LTD. AND JPMORGAN CHASE BANK, N.A., As Depositary AND HOLDERS OF AMERICAN DEPOSITARY RECEIPTS DEPOSIT AGREEMENT CONTENTS Page PARTIES 1 RECITALS 1 Section 1. Certain Definitions 1 (a) ADR Register 1 (b) ADRs; Direct Registration ADRs 1 (c) ADS 1 (d) Custodian 1 (e) Deliver, execute, issue et al 1 (f) Delivery Order 1 (g) Deposit
November 9, 2007	F-6 POS	As filed with the U.S. Securities and Exchange Commission on November 9, 2007 Table of Contents As filed with the U.S. Securities and Exchange Commission on November 9, 2007 Registration No. 333-146876 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-6 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 For the American Depositary Shares Evidenced by American Depositary Receipts CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Exact
November 9, 2007	424B4	China Nepstar Chain Drugstore Ltd. 20,625,000 American Depositary Shares 41,250,000 Ordinary Shares 424B4 1 h01354b4e424b4.htm CHINA NEPSTAR CHAIN DRUGSTORE LTD. Table of Contents Filed Pursuant to Rule 424(b)(4) Registration No. 333-146767 China Nepstar Chain Drugstore Ltd. 20,625,000 American Depositary Shares Representing 41,250,000 Ordinary Shares This is an initial public offering of American depositary shares, or ADSs, of China Nepstar Chain Drugstore Ltd., or China Nepstar. China Nepstar
November 9, 2007	EX-1.A	DATED AS OF NOVEMBER 15, 2007 CHINA NEPSTAR CHAIN DRUGSTORE LTD. JPMORGAN CHASE BANK, N.A., As Depositary AND HOLDERS OF AMERICAN DEPOSITARY RECEIPTS DEPOSIT AGREEMENT EXHIBIT a DATED AS OF NOVEMBER 15, 2007 CHINA NEPSTAR CHAIN DRUGSTORE LTD. AND JPMORGAN CHASE BANK, N.A., As Depositary AND HOLDERS OF AMERICAN DEPOSITARY RECEIPTS DEPOSIT AGREEMENT CONTENTS Page PARTIES 1 RECITALS 1 Section 1. Certain Definitions 1 (a) ADR Register 1 (b) ADRs; Direct Registration ADRs 1 (c) ADS 1 (d) Custodian 1 (e) Deliver, execute, issue et al 1 (f) Delivery Order 1 (g) Deposit
November 9, 2007	EX-1.E	Certification under Rule 466 EX-1.E 3 h01615exv1we.htm EX-1.E CERTIFICATION UNDER RULE 466 EXHIBIT e Certification under Rule 466 The depositary, JPMorgan Chase Bank, N.A. represents and certifies the following: (1) That it previously had filed a registration statement on Form F-6 (China Nepstar Chain Drugstore Ltd., 333-146876) that the Commission declared effective, with terms of deposit identical to the terms of deposit of
November 5, 2007	EX-1.1	EX-1.1 Exhibit 1.1 CHINA NEPSTAR CHAIN DRUGSTORE LTD. AMERICAN DEPOSITARY SHARES REPRESENTING ORDINARY SHARES (PAR VALUE US$0.0001 PER SHARE) - UNDERWRITING AGREEMENT , 2007 Goldman Sachs (Asia) L.L.C. 68th Floor, Cheung Kong Center 2 Queen's Road Central Hong Kong Merrill Lynch, Pierce, Fenner & Smith Incorporated 4 World Financial Center 250 Vessey Street New York, NY 10080 As Representatives of the se
November 5, 2007	FWP	China Nepstar Chain Drugstore Ltd. Issuer Free Writing Prospectus Filed pursuant to Rule 433 Registration No. 333-146767 November 5, 2007 China Nepstar Chain Drugstore Ltd. China Nepstar Chain Drugstore Ltd., or China Nepstar, has filed a registration statement on Form F-1, including a prospectus, with the SEC for the offering to which this free writing prospectus relates. Before you invest, you should read the prospectus in that r
November 5, 2007	F-1/A	As filed with the Securities and Exchange Commission on November 5, 2007 Table of Contents As filed with the Securities and Exchange Commission on November 5, 2007 Registration No.
October 31, 2007	F-1/A	As filed with the Securities and Exchange Commission on October 31, 2007 CHINA NEPSTAR CHAIN DRUGSTORE LTD. Table of Contents As filed with the Securities and Exchange Commission on October 31, 2007 Registration No. 333-146767 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 to Form F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 China Nepstar Chain Drugstore Ltd. (Exact name of registrant as specified in its charter) Not Applicable
October 31, 2007	FWP	China Nepstar Chain Drugstore Ltd. Issuer Free Writing Prospectus Filed pursuant to Rule 433 Registration No. 333-146767 October 31, 2007 China Nepstar Chain Drugstore Ltd. China Nepstar Chain Drugstore Ltd., or China Nepstar, has filed a registration statement on Form F-1, including a prospectus, with the SEC for the offering to which this free writing prospectus relates. Before you invest, you should read the prospectus in that r
October 26, 2007	F-1/A	As filed with the Securities and Exchange Commission on October 26, 2007 CHINA NEPSTAR CHAIN DRUGSTORE LTD. Table of Contents As filed with the Securities and Exchange Commission on October 26, 2007 Registration No. 333-146767 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to Form F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 China Nepstar Chain Drugstore Ltd. (Exact name of registrant as specified in its charter) Not Applicable
October 26, 2007	EX-99.2	EX-99.2 Exhibit 99.2 (CHINESE CHARACTERS) HAIWEN & PARTNERS (Chinese Characters) 2 (Chinese Characters) 21 (Chinese Characters) 100027 21/F, Beijing Silver Tower, No. 2 Dong San Huan North Road Chaoyang District, Beijing 100027, P.R.China (Chinese Characters)(TEL): (86 10) 8441 5888 (Chinese Characters)(FAX): (86 10) 8441 5999 TO: CHINA NEPSTAR CHAIN DRUGSTORE LTD. 6th floor, Tower B, Xinnengyuan Building
October 23, 2007	F-6	As filed with the U.S. Securities and Exchange Commission on October 23, 2007 Table of Contents As filed with the U.S. Securities and Exchange Commission on October 23, 2007 Registration No. 333-[ ] SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-6 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 For the American Depositary Shares Evidenced by American Depositary Receipts CHINA NEPSTAR CHAIN DRUGSTORE LTD. (Exact name of issuer of deposited securitie
October 23, 2007	EX-1.D	October 23, 2007 EX-1.D 3 h01550exv1wd.htm EX-1.D OPINION OF CLIFFORD CHANCE EXHIBIT d October 23, 2007 JPMorgan Chase Bank, N.A., as Depositary Four New York Plaza New York, New York 10004 Dear Sirs American Depositary Shares evidenced by American Depositary Receipts for deposited ordinary shares of China Nepstar Chain Drugstore Ltd. Referring to the Registration Statement on Form F-6 relating to the above-entitl
October 23, 2007	EX-1.A	DATED AS OF , 2007 CHINA NEPSTAR CHAIN DRUGSTORE LTD. JPMORGAN CHASE BANK, N.A., As Depositary AND HOLDERS OF AMERICAN DEPOSITARY RECEIPTS DEPOSIT AGREEMENT EXHIBIT a DATED AS OF , 2007 CHINA NEPSTAR CHAIN DRUGSTORE LTD. AND JPMORGAN CHASE BANK, N.A., As Depositary AND HOLDERS OF AMERICAN DEPOSITARY RECEIPTS DEPOSIT AGREEMENT CONTENTS Page PARTIES 1 RECITALS 1 Section 1. Certain Definitions 1 (a) ADR Register 1 (b) ADRs; Direct Registration ADRs 1 (c) ADS 1 (d) Custodian 1 (e) Deliver, execute, issue et al 1 (f) Delivery Order 1 (g) Deposited Securiti
October 17, 2007	EX-10.7.2	EX-10.7.2 Exhibit 10.7.2 ENTRUSTMENT LOAN AGREEMENT Serial No. Xing Yin Shen Ba Gua Ling (2007) No. 002 Entrusting Party: Shenzhen Nepstar Pharmaceutical Co., Ltd. Mail Address: Neptunus Building A-15B, Nanshan District, Shenzhen Mail Code: 518052 Contact Tel.: 26649838 Lender: Shenzhen Branch of Industrial Bank Co., Ltd. Mail Address: No. 39 Ba Gua Yi Road Mail Code: 518029 Contact Tel.: 25982763 Borrower:
October 17, 2007	EX-10.9.1	EX-10.9.1 Exhibit 10.9.1 EQUITY PLEDGE AGREEMENT This Equity Pledge Agreement (hereinafter referred to as this "Agreement") is entered into by and between the following parties on June 22, 2007 in Shenzhen: PLEDGEE: PARTY A: SHENZHEN NEPSTAR PHARMACEUTICAL CO., LTD. Registered address: Neptunus Building A-15B, Nanshan District, Shenzhen PLEDGORS: PARTY B: SHENZHEN NEPSTAR MANAGEMENT CONSULTING CO., LTD. Reg
October 17, 2007	EX-4.3	EX-4.3 EX-4.3 5 h01354exv4w3.txt EX-4.3 FORM OF DEPOSIT AGREEMENT (CLIFFORD CHANCE LOGO) Exhibit 4.3 (CHINESE CHARACTERS) DATED AS OF [] 2007 CHINA NEPSTAR CHAIN DRUGSTORE LTD. AND JPMORGAN CHASE BANK, N.A., As Depositary AND HOLDERS OF AMERICAN DEPOSITARY RECEIPTS - DEPOSIT AGREEMENT - CONTENTS PAGE - PARTIES.................................................................. 1 RECITALS...................
October 17, 2007	EX-10.14	EX-10.14 Exhibit 10.14 TRADEMARK LICENSE AGREEMENT Licensor: Shenzhen Nepstunus Group Co., Ltd. (hereinafter referred to as "Party A") Licensee: Shenzhen Nepstar Pharmaceutical Co., Ltd. (hereinafter referred to as "Party B") In accordance with relevant provisions of Trademark Law of the People's Republic of China, under the principles of free will and faithfulness, through negotiation, Party A and Party B
October 17, 2007	EX-99.1	EX-99.1 Exhibit 99.1 CODE OF BUSINESS CONDUCT AND ETHICS OF CHINA NEPSTAR CHAIN DRUGSTORE LTD. I. PURPOSE China Nepstar Chain Drugstore Ltd. and its subsidiaries (collectively the "Company") is committed to conduct its business in accordance with applicable laws, rules and regulations and the highest standards of business ethics. This Code of Business Conduct and Ethics (the "Code") contains general guide
October 17, 2007	EX-10.3	EX-10.3 Exhibit 10.3 CHINA NEPSTAR CHAIN DRUGSTORE LTD. 2007 SHARE INCENTIVE PLAN 1. PURPOSE OF THE PLAN The purpose of the Plan is to aid the Company and its Affiliates in recruiting and retaining key employees, directors or consultants of outstanding ability and to motivate such employees, directors or consultants to exert their best efforts on behalf of the Company and its Affiliates by providing incen
October 17, 2007	EX-10.8.3	EX-10.8.3 Exhibit 10.8.3 TO: SHENZHEN NEPSTAR PHARMACEUTICAL CO., LTD. COMMITMENT LETTER I, Zhou Liping, as the shareholder of Shenzhen Nepstar Information and Technology Service Co., Ltd. (hereinafter referred to as "Nepstar IT"), holds 100% equity of such company. On April 28, 2007, Nepstar IT, Shenzhen Nepstar Pharmaceutical Co., Ltd. ("Nepstar Pharmaceutical") and Shenzhen Nepstar Management Consulting
October 17, 2007	EX-10.7.1	EX-10.7.1 Exhibit 10.7.1 ENTRUSTMENT LOAN AGREEMENT Serial No. Xing Yin Shen Ba Gua Ling (2007) No. 003 Entrusting Party: Shenzhen Nepstar Pharmaceutical Co., Ltd. Mail Address: Neptunus Building A-15B, Nanshan District, Shenzhen Mail Code: 518052 Contact Tel.: 26649838 Lender: Shenzhen Branch of Industrial Bank Co., Ltd. Mail Address: No. 39 Ba Gua Yi Road Mail Code: 518029 Contact Tel.: 25982763 Borrower:

NPD / China Nepstar Chain Drugstore Ltd. - SEC-arkiveringar, Årsredovisning, Fullmaktsutlåtande

Grundläggande statistik

SEC Filings

SEC Filings (Chronological Order)